SearcharxivSearch

arXiv subjects

Vaclav Kremen

Publications and source records attributed to Vaclav Kremen.

2 recordsLinked to original sources

EEG Foundation Models: A Critical Review of Current Progress and Future Directions

Premise. Patterns of electrical brain activity recorded via electroencephalography (EEG) offer immense value for scientific and clinical investigations. The inability of supervised EEG encoders to learn robust EEG patterns and their over-reliance on expensive signal annotations have sparked a transition towards general-purpose self-supervised EEG encoders, i.e., EEG foundation models (EEG-FMs), for robust and scalable EEG feature extraction. However, the real-world readiness of early EEG-FMs and the rubrics for long-term research progress remain unclear. Objective. In this work, we conduct a review of ten early EEG-FMs to capture common trends and identify key directions for future development of EEG-FMs. Methods. We comparatively analyze each EEG-FM using three fundamental pillars of foundation modeling, namely the representation of input data, self-supervised modeling, and the evaluation strategy. Based on this analysis, we present a critical synthesis of EEG-FM methodology, empirical findings, and outstanding research gaps. Results. We find that most EEG-FMs adopt a sequence-based modeling scheme that relies on transformer-based backbones and the reconstruction of masked temporal EEG sequences for self-supervision. However, model evaluations remain heterogeneous and largely limited, making it challenging to assess their practical off-the-shelf utility. In addition to adopting standardized and realistic evaluations, future work should demonstrate more substantial scaling effects and make principled and trustworthy choices throughout the EEG representation learning pipeline. Significance. Our review indicates that the development of benchmarks, software tools, technical methodologies, and applications in collaboration with domain experts may advance the translational utility and real-world adoption of EEG-FMs.

eess.SP

Integrating Artificial Intelligence with Real-time Intracranial EEG Monitoring to Automate Interictal Identification of Seizure Onset Zones in Focal Epilepsy

An ability to map seizure-generating brain tissue, i.e., the seizure onset zone (SOZ), without recording actual seizures could reduce the duration of invasive EEG monitoring for patients with drug-resistant epilepsy. A widely-adopted practice in the literature is to compare the incidence (events/time) of putative pathological electrophysiological biomarkers associated with epileptic brain tissue with the SOZ determined from spontaneous seizures recorded with intracranial EEG, primarily using a single biomarker. Clinical translation of the previous efforts suffers from their inability to generalize across multiple patients because of (a) the inter-patient variability and (b) the temporal variability in the epileptogenic activity. Here, we report an artificial intelligence-based approach for combining multiple interictal electrophysiological biomarkers and their temporal characteristics as a way of accounting for the above barriers and show that it can reliably identify seizure onset zones in a study cohort of 82 patients who underwent evaluation for drug-resistant epilepsy. Our investigation provides evidence that utilizing the complementary information provided by multiple electrophysiological biomarkers and their temporal characteristics can significantly improve the localization potential compared to previously published single-biomarker incidence-based approaches, resulting in an average area under ROC curve (AUC) value of 0.73 in a cohort of 82 patients. Our results also suggest that recording durations between ninety minutes and two hours are sufficient to localize SOZs with accuracies that may prove clinically relevant. The successful validation of our approach on a large cohort of 82 patients warrants future investigation on the feasibility of utilizing intra-operative EEG monitoring and artificial intelligence to localize epileptogenic brain tissue.

q-bio.NC